Harel Insurance Investments & Financial Services Ltd. sells 1,272 shares of DocuSign, Inc. (NASDAQ:DOCU)


Harel Insurance Investments & Financial Services Ltd. has reduced the number of shares of DocuSign, Inc.NASDAQ: DOCUGet Votes) and 52.4% in the 1st quarter, according to information recently released by the SEC. The investor owned 1,154 shares of the company’s stock after selling 1,272 shares during the period. Harel Insurance Investments & Financial Services Ltd. in DocuSign was worth $124,000 as of its most recent filing with the SEC.

A number of other businesses and hedge funds have bought and sold shares of the stock. Carson Advisory Inc. bought a new stake in DocuSign in the first quarter valued at $244,000. Truvestments Capital LLC raised its holdings in DocuSign by 11.8% in the first quarter. Truvestments Capital LLC now owns 2,745 shares of the company’s stock valued at $294,000 after acquiring an additional 289 shares in the last quarter. Congress Park Capital LLC lifted its holdings in DocuSign by 181.9% in the first quarter. Congress Park Capital LLC now owns 4,130 shares of the company’s stock worth $442,000 after acquiring an additional 2,665 shares in the last quarter. National Asset Management Inc. lifted its holdings in DocuSign by 5.4% in the first quarter. National Asset Management Inc. now owns 14,876 shares of the company’s stock valued at $1,594,000 after acquiring an additional 757 shares in the last quarter. Finally, Atria Investments LLC bought a new stake in DocuSign in the first quarter valued at about $1,674,000. Institutional investors own 75.62% of the company’s stock.

Analyst Upgrades and Downgrades

DOCU has been the subject of several investigative reports. Wolfe Research downgraded DocuSign from a “market perform” rating to an “underperform” rating and set a $50.00 price objective on the stock. in research notes on Monday, June 13th. JMP Securities dropped their price objective on DocuSign from $180.00 to $151.00 and set a “market outperform” rating on the stock in a research note on Friday, June 10th. Royal Bank of Canada dropped their target price on DocuSign from $85.00 to $80.00 in a research note on Friday, June 10th. Citigroup dropped their target price on DocuSign from $114.00 to $90.00 and set a “buy” rating on the stock in a research note on Friday, June 10th. Finally, Wells Fargo & Company lowered their target price on DocuSign from $80.00 to $63.00 and set an “equal weight” rating on the stock in a research note on Friday, June 10th. Four equities research analysts have rated the stock with a sell rating, eight have issued a hold rating and four have assigned a buy rating to the company. According to data from MarketBeat.com, the stock has a consensus rating of “Hold” and a price target of $131.20.

DocuSign Stock Performance

Sections a NASDAQ: DOCU opened at $64.45 on Monday. The 50-day moving average is $69.82 and the 200-day moving average is $92.55. DocuSign, Inc. it has a one year low of $55.86 and a one year high of $314.76. The company has a debt ratio of 2.06, a current ratio of 1.01 and a quick ratio of 1.01.

DocuSign (NASDAQ: DOCUGet Votes) last reported its earnings results on Thursday, June 9. The company reported $0.38 earnings per share, missing analysts’ consensus estimates of $0.46 and ($0.08). The business had revenue of $588.69 million for the quarter, compared to analyst estimates of $581.85 million. DocuSign had a margin of error of 4.00% and a margin of error of 17.17%. The company’s revenue for the quarter was up 25.5% compared to the same quarter last year. During the same period last year, the business posted ($0.03) EPS. On average, analysts expect that DocuSign, Inc. it will provide -0.48 earnings per share for the fiscal year.

About DocuSign

(Get Votes)

DocuSign, Inc provides electronic signature software in the United States and around the world. The company provides an e-signature solution that helps businesses prepare, sign, execute, and manage contracts. It also provides CLM, which uses workflows for all aspects of the contract; Intelligence that uses artificial intelligence (AI) to search and analyze contracts and legal concepts and clauses; Gen for Salesforce, which allows sales reps to automatically create contracts with a few clicks from within Salesforce; Negotiate for Salesforce which supports approval, document matching, and quality control; Analyzer, which helps customers understand what they are signing before they sign; and CLM+ which provides AI-powered contract management.

Recommended Articles

Want to see what other hedge funds are holding DOCU? Go to HoldingsChannel.com to access the latest 13F filings and internal sales of DocuSign, Inc.NASDAQ: DOCUGet Votes).



Receive DocuSign Daily News & Reviews – Enter your email address below to receive a FREE daily summary of the latest news and expert opinions on DocuSign and related companies with MarketBeat.com’s FREE daily email newsletter.